10 Best Undervalued Large Cap Stocks for November 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The 2025 market landscape is defined by rapid technological innovation, shifting healthcare dynamics, and evolving consumer demand. At ValueSense, our stock selection methodology leverages a blend of quantitative and qualitative analysis, focusing on intrinsic value, quality ratings, and sector diversification. We prioritize companies with strong fundamentals, robust free cash flow, and favorable growth prospects, as identified by our proprietary screening and valuation tools[1][2]. Each stock featured below is selected based on its relative undervaluation, sector leadership, and potential for long-term value creation.
Featured Stock Analysis
Stock #1: Taiwan Semiconductor Manufacturing Company Limited (TSM)
| Metric | Value |
|---|---|
| Market Cap | $1,558.3B |
| Quality Rating | 8.2 |
| Intrinsic Value | $415.7 |
| 1Y Return | 58.1% |
| Revenue | NT$3,631.4B |
| Free Cash Flow | NT$889.9B |
| Revenue Growth | 37.0% |
| FCF margin | 24.5% |
| Gross margin | 59.0% |
| ROIC | 36.2% |
| Total Debt to Equity | 19.0% |
Investment Thesis
Taiwan Semiconductor Manufacturing Company (TSM) stands as the world’s largest dedicated semiconductor foundry, powering the global technology supply chain. With a market cap of $1,558.3B and a stellar 1-year return of 58.1%, TSM’s dominance is underpinned by its advanced manufacturing capabilities and strategic partnerships with leading chip designers. The company’s intrinsic value is estimated at $415.7, suggesting further upside potential. TSM’s robust revenue growth of 37.0% and a free cash flow margin of 24.5% highlight its operational efficiency and capacity to reinvest for future innovation.
Key Catalysts
- Leadership in advanced semiconductor process technology (e.g., 3nm, 5nm nodes)
- Expanding demand for AI, automotive, and high-performance computing chips
- Strong free cash flow NT$889.9B supporting capital expenditure and R&D
- High gross margin 59.0% and exceptional ROIC 36.2%
Risk Factors
- Geopolitical tensions in the Taiwan Strait impacting supply chain stability
- Cyclical nature of semiconductor demand
- High capital intensity and technological obsolescence risk
Stock #2: Berkshire Hathaway Inc. (BRK-B)
| Metric | Value |
|---|---|
| Market Cap | $1,030.9B |
| Quality Rating | 6.0 |
| Intrinsic Value | $645.0 |
| 1Y Return | 5.9% |
| Revenue | $370.2B |
| Free Cash Flow | $8,225.0M |
| Revenue Growth | 0.0% |
| FCF margin | 2.2% |
| Gross margin | 24.2% |
| ROIC | 11.3% |
| Total Debt to Equity | 19.0% |
Investment Thesis
Berkshire Hathaway, led by Warren Buffett, is a diversified conglomerate with holdings spanning insurance, utilities, manufacturing, and consumer goods. With a market cap of $1,030.9B and a conservative 1-year return of 5.9%, Berkshire is valued for its stability and disciplined capital allocation. The company’s intrinsic value is calculated at $645.0, and its quality rating of 6.0 reflects a strong, albeit mature, business model. Despite flat revenue growth, Berkshire’s vast cash reserves and diversified portfolio provide resilience in volatile markets.
Key Catalysts
- Defensive positioning through insurance and utility subsidiaries
- Strategic acquisitions and share buybacks
- Strong free cash flow $8,225.0M supporting long-term investments
Risk Factors
- Slower revenue growth 0.0% compared to peers
- Succession planning concerns post-Buffett era
- Exposure to macroeconomic cycles through industrial holdings
Stock #3: Alibaba Group Holding Limited (BABA)
| Metric | Value |
|---|---|
| Market Cap | $393.8B |
| Quality Rating | 6.2 |
| Intrinsic Value | $471.6 |
| 1Y Return | 73.9% |
| Revenue | CN¥1,000.8B |
| Free Cash Flow | CN¥25.9B |
| Revenue Growth | 5.3% |
| FCF margin | 2.6% |
| Gross margin | 41.2% |
| ROIC | 15.8% |
| Total Debt to Equity | 21.2% |
Investment Thesis
Alibaba is a leading Chinese e-commerce and cloud computing giant, with a market cap of $393.8B and a remarkable 1-year return of 73.9%. The company’s intrinsic value is estimated at $471.6, indicating significant undervaluation relative to current market price. Alibaba’s revenue growth of 5.3% and a gross margin of 41.2% reflect its scale and operational leverage, while its quality rating of 6.2 signals a balanced risk-reward profile.
Key Catalysts
- Recovery in Chinese consumer spending and digital transformation
- Expansion of cloud services and international e-commerce
- Strong brand equity and ecosystem integration
Risk Factors
- Regulatory uncertainty and government intervention in China
- Intensifying competition in e-commerce and cloud markets
- Currency and geopolitical risks affecting cross-border operations
Stock #4: AbbVie Inc. (ABBV)
| Metric | Value |
|---|---|
| Market Cap | $386.4B |
| Quality Rating | 6.1 |
| Intrinsic Value | $286.5 |
| 1Y Return | 8.0% |
| Revenue | $58.3B |
| Free Cash Flow | $18.2B |
| Revenue Growth | 6.1% |
| FCF margin | 31.3% |
| Gross margin | 74.3% |
| ROIC | 12.6% |
| Total Debt to Equity | (51,073.2%) |
Investment Thesis
AbbVie is a global biopharmaceutical company known for its immunology and oncology portfolios. With a market cap of $386.4B and a 1-year return of 8.0%, AbbVie’s intrinsic value is pegged at $286.5. The company boasts a high free cash flow margin 31.3% and an exceptional gross margin 74.3%, supporting ongoing R&D and dividend payments. Its quality rating of 6.1 reflects a solid but competitive position in the healthcare sector.
Key Catalysts
- Blockbuster drugs in immunology and oncology pipelines
- Strong free cash flow $18.2B enabling shareholder returns
- Strategic acquisitions to diversify revenue streams
Risk Factors
- Patent expirations and biosimilar competition
- High total debt to equity ratio (notably negative, indicating complex capital structure)
- Regulatory and pricing pressures in pharmaceuticals
Stock #5: UnitedHealth Group Incorporated (UNH)
| Metric | Value |
|---|---|
| Market Cap | $310.1B |
| Quality Rating | 6.2 |
| Intrinsic Value | $598.9 |
| 1Y Return | -39.3% |
| Revenue | $435.2B |
| Free Cash Flow | $17.4B |
| Revenue Growth | 11.8% |
| FCF margin | 4.0% |
| Gross margin | 19.7% |
| ROIC | 19.0% |
| Total Debt to Equity | 78.9% |
Investment Thesis
UnitedHealth Group is a leading health insurance and services provider, with a market cap of $310.1B. Despite a negative 1-year return of -39.3%, the company’s intrinsic value is $598.9, suggesting potential for recovery. UnitedHealth’s revenue growth of 11.8% and a quality rating of 6.2 highlight its scale and operational efficiency. The company’s diversified business model spans insurance, healthcare services, and technology solutions.
Key Catalysts
- Growth in managed care and healthcare technology segments
- Expanding Medicare Advantage and Medicaid enrollment
- Strong free cash flow $17.4B supporting innovation
Risk Factors
- Regulatory changes and reimbursement risk
- Rising healthcare costs and competitive pressures
- Elevated debt levels (total debt to equity: 78.9%)
Stock #6: SAP SE (SAP)
| Metric | Value |
|---|---|
| Market Cap | $303.4B |
| Quality Rating | 6.4 |
| Intrinsic Value | $303.0 |
| 1Y Return | 11.3% |
| Revenue | €36.5B |
| Free Cash Flow | €6,482.0M |
| Revenue Growth | 9.7% |
| FCF margin | 17.8% |
| Gross margin | 73.5% |
| ROIC | 16.6% |
| Total Debt to Equity | 21.1% |
Investment Thesis
SAP is a global leader in enterprise software, with a market cap of $303.4B and a 1-year return of 11.3%. The company’s intrinsic value is $303.0, closely aligned with its market price, and a quality rating of 6.4. SAP’s revenue growth of 9.7% and high gross margin 73.5% underscore its strong recurring revenue base and cloud transition.
Key Catalysts
- Accelerated adoption of cloud-based ERP solutions
- Expansion into AI-driven business analytics
- Strong free cash flow €6,482.0M and robust profitability
Risk Factors
- Intense competition from U.S. tech giants
- Currency fluctuations impacting international revenue
- Execution risk in cloud transformation
Stock #7: Cisco Systems, Inc. (CSCO)
| Metric | Value |
|---|---|
| Market Cap | $289.5B |
| Quality Rating | 6.6 |
| Intrinsic Value | $78.2 |
| 1Y Return | 34.4% |
| Revenue | $56.7B |
| Free Cash Flow | $13.3B |
| Revenue Growth | 5.3% |
| FCF margin | 23.5% |
| Gross margin | 65.1% |
| ROIC | 13.3% |
| Total Debt to Equity | 63.3% |
Investment Thesis
Cisco is a networking and cybersecurity leader, with a market cap of $289.5B and a 1-year return of 34.4%. Its intrinsic value is $78.2, and a quality rating of 6.6 reflects its strong market position. Cisco’s revenue growth of 5.3% and a free cash flow margin of 23.5% highlight its ability to generate cash and invest in innovation.
Key Catalysts
- Growth in cloud networking and cybersecurity demand
- Expansion into software and recurring revenue streams
- Strong free cash flow $13.3B and high gross margin 65.1%
Risk Factors
- Competitive pressures from emerging tech firms
- Cyclical IT spending patterns
- Elevated debt levels (total debt to equity: 63.3%)
Stock #8: Toyota Motor Corporation (TM)
| Metric | Value |
|---|---|
| Market Cap | $266.1B |
| Quality Rating | 6.3 |
| Intrinsic Value | $477.3 |
| 1Y Return | 18.0% |
| Revenue | ¥48.5T |
| Free Cash Flow | ¥44.4B |
| Revenue Growth | 4.5% |
| FCF margin | 0.1% |
| Gross margin | 19.3% |
| ROIC | 8.0% |
| Total Debt to Equity | 103.9% |
Investment Thesis
Toyota is a global automotive leader, with a market cap of $266.1B and a 1-year return of 18.0%. The company’s intrinsic value is $477.3, and a quality rating of 6.3. Toyota’s revenue growth of 4.5% and a low free cash flow margin 0.1% reflect the capital-intensive nature of the auto industry, but its scale and innovation in hybrid and electric vehicles provide long-term growth levers.
Key Catalysts
- Leadership in hybrid and electric vehicle technology
- Global brand strength and manufacturing scale
- Expansion into mobility services and autonomous driving
Risk Factors
- Supply chain disruptions and raw material cost volatility
- Regulatory changes impacting emissions standards
- High debt levels (total debt to equity: 103.9%)
Stock #9: Micron Technology, Inc. (MU)
| Metric | Value |
|---|---|
| Market Cap | $249.7B |
| Quality Rating | 8.4 |
| Intrinsic Value | $368.6 |
| 1Y Return | 124.8% |
| Revenue | $37.4B |
| Free Cash Flow | $8,929.0M |
| Revenue Growth | 48.9% |
| FCF margin | 23.9% |
| Gross margin | 39.8% |
| ROIC | 15.9% |
| Total Debt to Equity | 27.2% |
Investment Thesis
Micron Technology is a leading memory and storage solutions provider, with a market cap of $249.7B and an impressive 1-year return of 124.8%. The company’s intrinsic value is $368.6 and boasts a high quality rating of 8.4. Micron’s revenue growth of 48.9% and a free cash flow margin of 23.9% highlight its strong position in the data-driven economy.
Key Catalysts
- Surging demand for DRAM and NAND in AI, cloud, and automotive markets
- Technological leadership in next-generation memory products
- Strong free cash flow $8,929.0M and improving profitability
Risk Factors
- Cyclical pricing in memory markets
- Capital intensity and rapid technology shifts
- Trade tensions affecting global supply chains
Stock #10: Salesforce, Inc. (CRM)
| Metric | Value |
|---|---|
| Market Cap | $249.0B |
| Quality Rating | 6.9 |
| Intrinsic Value | $270.9 |
| 1Y Return | -10.5% |
| Revenue | $39.5B |
| Free Cash Flow | $12.5B |
| Revenue Growth | 8.3% |
| FCF margin | 31.6% |
| Gross margin | 77.6% |
| ROIC | 10.8% |
| Total Debt to Equity | 4.6% |
Investment Thesis
Salesforce is a global leader in customer relationship management (CRM) software, with a market cap of $249.0B. Despite a negative 1-year return of -10.5%, the company’s intrinsic value is $270.9 and a quality rating of 6.9. Salesforce’s revenue growth of 8.3% and a high free cash flow margin 31.6% underscore its recurring revenue model and innovation in AI-driven business applications.
Key Catalysts
- Expansion of AI and automation capabilities within CRM platform
- Growth in enterprise digital transformation initiatives
- Strong free cash flow $12.5B and industry-leading gross margin 77.6%
Risk Factors
- Slowing growth in core CRM market
- Integration risks from acquisitions
- Competitive pressures from large tech firms
Portfolio Diversification Insights
This watchlist spans technology, healthcare, financials, automotive, and consumer sectors, providing a balanced approach to sector allocation. Technology stocks (TSM, MU, CSCO, SAP, CRM) offer growth and innovation, while healthcare (ABBV, UNH) and financials (BRK-B) provide stability and defensive characteristics. Toyota adds exposure to global consumer trends and mobility innovation, and Alibaba offers access to emerging market growth. This diversification helps mitigate sector-specific risks and enhances the portfolio’s resilience across market cycles.
Market Timing & Entry Strategies
Entry strategies should consider both macroeconomic conditions and individual stock valuations. Investors may use dollar-cost averaging to reduce timing risk, or monitor technical and fundamental indicators for optimal entry points. ValueSense’s intrinsic value tools and backtesting features can help identify periods of undervaluation and validate entry strategies based on historical performance[1][2]. Monitoring earnings reports, sector trends, and regulatory developments is essential for informed decision-making.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- How VKTX (Viking Therapeutics) Makes Money in 2025: A Deep-Dive With Income Statement
- How NET (Cloudflare) Makes Money in 2025: A Deep-Dive With Income Statement
- How MASS (908 Devices) Makes Money in 2025: A Deep-Dive With Income Statement
- How CRVO (CervoMed) Makes Money in 2025: A Deep-Dive With Income Statement
- How GILD (Gilead Sciences) Makes Money in 2025: A Deep-Dive With Income Statement
FAQ Section
Q1: How were these stocks selected?
Stocks were chosen using ValueSense’s proprietary screening tools, focusing on intrinsic value, quality ratings, sector leadership, and fundamental metrics such as revenue growth, free cash flow, and return on invested capital[1][2].
Q2: What's the best stock from this list?
Each stock offers unique strengths; however, TSM and Micron Technology stand out for their high quality ratings and strong growth metrics. The “best” stock depends on individual investment goals and risk tolerance.
Q3: Should I buy all these stocks or diversify?
Diversification across sectors and geographies is a key principle of risk management. This watchlist is designed to provide exposure to multiple industries, reducing the impact of sector-specific volatility.
Q4: What are the biggest risks with these picks?
Risks include sector-specific challenges such as regulatory changes, technological disruption, geopolitical tensions, and macroeconomic headwinds. Each stock’s risk profile is detailed in its analysis above.
Q5: When is the best time to invest in these stocks?
Optimal timing depends on market conditions, individual stock valuations, and personal investment strategy. ValueSense’s intrinsic value and backtesting tools can help identify attractive entry points based on historical data and current fundamentals[1][2].